| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.005 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |